Your browser is no longer supported. Please, upgrade your browser.
Settings
TLGT Teligent, Inc. daily Stock Chart
TLGT [NASD]
Teligent, Inc.
Index- P/E- EPS (ttm)-0.38 Insider Own0.10% Shs Outstand56.07M Perf Week-8.39%
Market Cap73.45M Forward P/E100.77 EPS next Y0.01 Insider Trans64.57% Shs Float53.30M Perf Month-19.14%
Income-20.50M PEG- EPS next Q-0.03 Inst Own83.40% Short Float18.91% Perf Quarter-24.28%
Sales65.20M P/S1.13 EPS this Y36.20% Inst Trans-3.31% Short Ratio22.13 Perf Half Y-64.50%
Book/sh0.67 P/B1.96 EPS next Y107.10% ROA-15.00% Target Price5.33 Perf Year-58.54%
Cash/sh0.27 P/C4.80 EPS next 5Y15.00% ROE-70.20% 52W Range1.13 - 4.52 Perf YTD-4.38%
Dividend- P/FCF- EPS past 5Y-7.90% ROI-2.50% 52W High-71.02% Beta1.60
Dividend %- Quick Ratio0.90 Sales past 5Y51.00% Gross Margin34.60% 52W Low15.93% ATR0.14
Employees183 Current Ratio1.30 Sales Q/Q61.90% Oper. Margin-26.30% RSI (14)37.60 Volatility13.56% 10.24%
OptionableYes Debt/Eq3.98 EPS Q/Q56.30% Profit Margin-42.90% Rel Volume0.95 Prev Close1.29
ShortableYes LT Debt/Eq3.30 EarningsMar 18 BMO Payout- Avg Volume455.52K Price1.31
Recom2.00 SMA20-9.93% SMA50-16.85% SMA200-54.17% Volume431,215 Change1.55%
Mar-19-19 02:06PM  Teligent, Inc. Announces FDA Approval of Fluocinonide Topical Solution USP, 0.05% GlobeNewswire
Mar-18-19 02:16PM  Edited Transcript of TLGT earnings conference call or presentation 18-Mar-19 12:00pm GMT Thomson Reuters StreetEvents -7.14%
08:01AM  Teligent: 4Q Earnings Snapshot Associated Press
07:45AM  Teligent, Inc. Announces Fourth Quarter and Year End 2018 Results GlobeNewswire
06:00AM  Teligent, Inc. to Host Earnings Call ACCESSWIRE
Mar-15-19 04:15PM  Teligent, Inc. to Present at the 31st Annual ROTH Conference Tuesday March 19, 2019 GlobeNewswire
Mar-14-19 08:15AM  Teligent, Inc. Announces FDA Approval of Desonide Ointment, 0.05% GlobeNewswire
Mar-12-19 04:15PM  Teligent, Inc. to Hold Conference Call for Fourth Quarter 2018 Results GlobeNewswire
Feb-28-19 04:31PM  Penny Stocks to Buy Using Technical Analysis for March 2019 Investopedia
Feb-27-19 01:08PM  Teligent, Inc. to Present at The 8th Annual SVB Leerink Global Healthcare Conference Friday March 1, 2019 GlobeNewswire
Jan-24-19 01:30PM  4 Pharma Stocks Leading Thursday's Bull Charge ACCESSWIRE
08:57AM  Teligent stock up 12% after FDA approves generic steroid cream MarketWatch
08:30AM  Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Ointment USP, 0.05% GlobeNewswire
Jan-02-19 08:30AM  Teligent, Inc. Announces FDA Approval of Gentamicin Sulfate Ointment USP, 0.1% GlobeNewswire
Dec-13-18 06:33PM  Teligent, Inc. Executes $120 Million Financing Agreement GlobeNewswire -7.48%
Dec-03-18 07:50AM  Factors of Influence in 2018, Key Indicators and Opportunity within Caesars Entertainment, Intercept Pharmaceuticals, Exxon Mobil, Teligent, Amerco, and Mettler-Toledo International New Research Emphasizes Economic Growth GlobeNewswire
Nov-16-18 05:15PM  Teligent, Inc. Receives Notification of Deficiency From NASDAQ Related to the Delayed Filing of Form 10-Q GlobeNewswire
Nov-14-18 01:36AM  Edited Transcript of TLGT earnings conference call or presentation 13-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -10.06%
Nov-13-18 05:37PM  Teligent: 3Q Earnings Snapshot Associated Press
04:15PM  Teligent, Inc. Announces Third Quarter 2018 Results GlobeNewswire
04:15PM  Teligent, Inc. Announces $120 Million Financing Commitment From Ares GlobeNewswire
Nov-12-18 08:30AM  Teligent, Inc. to Hold Conference Call for Third Quarter 2018 Results GlobeNewswire
Nov-02-18 08:45AM  Teligent, Inc. to Present at Jefferies London Healthcare Conference on Wednesday November 14, 2018 GlobeNewswire +6.13%
Oct-29-18 10:31AM  Teligent (TLGT) Q3 Earnings Preview: What's Shaping Up? Zacks
Oct-24-18 08:45AM  Teligent, Inc. Announces FDA Approval of Desoximetasone Ointment USP 0.05% GlobeNewswire
08:15AM  New Research: Key Drivers of Growth for Cedar Realty Trust, Vonage, Symantec, Teligent, UGI, and Welbilt Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Oct-17-18 08:45AM  Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.05% GlobeNewswire
Oct-11-18 02:15PM  What You Must Know About Teligent Incs (NASDAQ:TLGT) Market Risks Simply Wall St.
Oct-02-18 08:56AM  Teligent, Inc. Announces FDA Approval of Fluocinonide Ointment USP, 0.05% GlobeNewswire
Sep-26-18 08:39AM  Is the Options Market Predicting a Spike in Teligent (TLGT) Stock? Zacks
Sep-11-18 04:27PM  Edited Transcript of TLGT earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-16-18 04:30PM  Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage GlobeNewswire
Aug-14-18 08:30AM  Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage CNW Group
Aug-09-18 08:39AM  The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings Benzinga
07:30AM  Teligent (TLGT) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:16AM  Teligent: 2Q Earnings Snapshot Associated Press
Aug-08-18 04:15PM  Teligent, Inc. Announces Second Quarter 2018 Results GlobeNewswire
02:30PM  Teligent, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-18 09:30AM  TEVA vs. TLGT: Which Stock Is the Better Value Option? Zacks
Aug-03-18 08:30AM  Teligent, Inc. to Hold Conference Call for Second Quarter 2018 Results GlobeNewswire
Jul-30-18 08:30AM  Teligent, Inc. Announces FDA Approval of Hydrocortisone Lotion USP, 2.5% GlobeNewswire
Jul-24-18 03:03PM  Teligent, Inc. Announces FDA Approval of Hydrocortisone Cream USP, 2.5% GlobeNewswire
Jul-19-18 09:50AM  AGN or TLGT: Which Is the Better Value Stock Right Now? Zacks
09:45AM  AGN vs. TLGT: Which Stock Should Value Investors Buy Now? Zacks
Jul-10-18 03:34PM  Pure Global Cannabis Inc. completes reverse takeover transaction with PureSinse Inc. CNW Group
Jul-02-18 08:00AM  Teligent, Inc. Announces FDA Approval of Lidocaine and Prilocaine Cream USP, 2.5%/2.5% GlobeNewswire +7.51%
Jun-29-18 07:35AM  New Research: Key Drivers of Growth for Webster Financial, Chimerix, Commerce Bancshares, Teligent, Pinnacle Financial Partners, and Empire State Realty Trust Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-20-18 09:22AM  Teligent, Inc. Announces FDA Approval of Fluocinonide Gel, 0.05% GlobeNewswire +6.22%
07:05AM  Breakfast Technical Briefing on Tesaro and Three Other Additional Biotech Stocks ACCESSWIRE
Jun-14-18 08:55AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +10.40%
08:11AM  Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi Benzinga
Jun-13-18 04:40PM  Teligent, Inc. Announces FDA Approval of Diflorasone Diacetate Ointment 0.05% GlobeNewswire
Jun-05-18 04:45PM  Teligent, Inc. Announces Closing Of $25 Million Secured Credit Facility GlobeNewswire
May-21-18 07:25AM  Stock Performance Review on Tesaro and Three Other Biotech Industry ACCESSWIRE -5.57%
May-17-18 07:30AM  Investor Expectations to Drive Momentum within Sun Communities, Anheuser-Busch InBev SA/NV, New Media Investment Group, Teligent, AptarGroup, and Pinnacle Financial Partners Discovering Underlying Factors of Influence GlobeNewswire
May-15-18 11:52AM  Edited Transcript of TLGT earnings conference call or presentation 8-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-08-18 09:01AM  Teligent: 1Q Earnings Snapshot Associated Press
08:00AM  Teligent, Inc. Announces First Quarter 2018 Results GlobeNewswire
May-07-18 06:36PM  Teligent, Inc. to Present at Deutsche Banks 43rd Annual Health Care Conference on Tuesday, May 8, 2018 GlobeNewswire
05:50PM  Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results GlobeNewswire
08:45AM  Teligent, Inc. to Host Earnings Call ACCESSWIRE
May-01-18 04:30PM  Teligent, Inc. to Present at Deutsche Banks 43rd Annual Health Care Conference on Tuesday May 8, 2018 GlobeNewswire
Apr-27-18 09:25AM  Teligent, Inc. Announces Agreements to Exchange Approximately $65 million of its 3.75% Senior Convertible Notes Due 2019 for 4.75% Senior Convertible Notes Due 2023 GlobeNewswire -12.64%
Apr-26-18 02:15PM  Teligent, Inc. to Hold Conference Call for First Quarter 2018 Results GlobeNewswire
Apr-17-18 04:35PM  Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05% GlobeNewswire
Apr-06-18 10:32AM  Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1% GlobeNewswire -6.31%
Mar-23-18 07:30AM  Blog Exposure - FDA Approved Teligents Halobetasol Propionate Ointment, 0.05% ACCESSWIRE
Mar-21-18 08:30AM  Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05% GlobeNewswire
Mar-16-18 05:21PM  Edited Transcript of TLGT earnings conference call or presentation 15-Mar-18 8:30pm GMT Thomson Reuters StreetEvents +20.97%
Mar-15-18 04:53PM  Teligent reports 4Q loss Associated Press -5.70%
04:10PM  Teligent, Inc. Announces Fourth Quarter and Year End 2017 Results GlobeNewswire
12:30PM  Teligent, Inc. to Host Earnings Call ACCESSWIRE
Mar-13-18 04:30PM  Teligent, Inc. to Present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday March 20, 2018 GlobeNewswire
Mar-12-18 04:30PM  Teligent, Inc. to Hold Conference Call for Fourth Quarter 2017 Results GlobeNewswire
Mar-05-18 04:30PM  Teligent, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday March 7, 2018 GlobeNewswire
Feb-14-18 09:31AM  Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05% GlobeNewswire
08:30AM  Investor Expectations to Drive Momentum within Amerco, Caesars Entertainment, Air Products and Chemicals, Consolidated Edison, Teligent, and Versartis Discovering Underlying Factors of Influence GlobeNewswire
Feb-13-18 06:02PM  Generic Drugmakers to Dump as Teva's Woes Continue in 2018 Zacks
Jan-26-18 08:40AM  Teligent, Inc. Announces the Appointment of Damian Finio as Chief Financial Officer GlobeNewswire
Jan-03-18 03:55PM  Teligent, Inc. to Present at the J.P. Morgan 36th Annual Healthcare Conference January 10th GlobeNewswire
Dec-27-17 11:56AM  ETFs with exposure to Teligent, Inc. : December 27, 2017 Capital Cube
Dec-14-17 11:00AM  Teva to lay off 14,000 workers in bid for survival but some are skeptical MarketWatch
Dec-11-17 09:27PM  Edited Transcript of TLGT earnings conference call or presentation 6-Nov-17 9:30pm GMT Thomson Reuters StreetEvents +6.54%
Nov-30-17 08:00AM  Report: Exploring Fundamental Drivers Behind Amerco, Caesars Entertainment, Air Products and Chemicals, Consolidated Edison, Teligent, and Versartis New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +6.91%
Nov-27-17 04:01PM  ETFs with exposure to Teligent, Inc. : November 27, 2017 Capital Cube
Nov-24-17 08:58AM  Teligent, Inc. :TLGT-US: Earnings Analysis: Q3, 2017 By the Numbers : November 24, 2017 Capital Cube +5.19%
Nov-22-17 08:30AM  Teligent, Inc. Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1% GlobeNewswire +10.24%
Nov-21-17 08:30AM  Teligent, Inc. Announces FDA Approval of Erythromycin Topical Solution USP, 2% GlobeNewswire
Nov-14-17 07:30AM  Featured Company News - FDA Approved Teligent's Betamethasone Dipropionate Ointment USP (Augmented), 0.05% ACCESSWIRE
Nov-10-17 09:20AM  Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05% GlobeNewswire +19.87%
Nov-07-17 01:22PM  Here's Why Teligent Stock Was Cut Nearly in Half Today Motley Fool -43.62%
07:40AM  Teligent shares drop nearly 40% after Q3 profit, revenue misses, lowered guidance MarketWatch
Nov-06-17 05:41PM  Teligent reports 3Q loss Associated Press
04:05PM  Teligent, Inc. Announces Third Quarter 2017 Results GlobeNewswire
Oct-26-17 10:00AM  Teligent, Inc. to Hold Conference Call for Third Quarter 2017 Results GlobeNewswire
Oct-17-17 08:10AM  Teligent, Inc. breached its 50 day moving average in a Bearish Manner : TLGT-US : October 17, 2017 Capital Cube
Oct-04-17 11:28AM  Teligent, Inc. Value Analysis (NASDAQ:TLGT) : October 4, 2017 Capital Cube
Oct-03-17 08:03AM  Teligent, Inc. breached its 50 day moving average in a Bullish Manner : TLGT-US : October 3, 2017 Capital Cube
Oct-02-17 01:38PM  Teligent, Inc. Announces FDA Approval of Partnered ANDA for Desonide Lotion, 0.05% GlobeNewswire +8.35%
Sep-19-17 08:00AM  Teligent, Inc. Announces FDA Approval of Triamcinolone Acetonide Cream USP, 0.1% GlobeNewswire
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's products are used in various applications that range from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, it offers contract manufacturing and formulation services. Teligent, Inc. sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Richardson StephenChief Scientific OfficerDec 14Buy1.7812,00021,37251,209Dec 14 12:52 PM
Finio DamianCFODec 14Buy1.8210,00018,20010,000Dec 14 12:48 PM
Richardson StephenChief Scientific OfficerOct 05Option Exercise0.008,333023,077Oct 22 09:45 PM
Grenfell-Gardner JasonPresident & CEOSep 04Sale4.0052,800211,20194,849Sep 05 04:45 PM
Wilson MartinGeneral CounselApr 25Option Exercise0.005,00005,000Oct 22 09:45 PM